IL1B and neoplasm: Previous work by our department found elevated levels of IL-1β in tumour samples compared to squamous epithelium from the same patients, and IL-1β levels were significantly decreased in the TCM generated from post treatment biopsies, compared to the TCM generated from pre-treatment biopsies in matched patients who achieved a complete pathological response to neoCRT9.